Best Buy Co., Inc. - Q1 2026 (Ended May 3, 2025) Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the first quarter of fiscal 2026, ended May 3, 2025. Best Buy operates two reportable segments: Domestic (U.S. operations and Best Buy Health) and International (Canada). The company reported 1,108 total stores as of period end. The quarter included 13 weeks, consistent with the prior year period.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | $8,767 million | $8,847 million |
| Comparable Sales | -0.7% | -6.1% |
| Gross Profit | $2,049 million (23.4% margin) | $2,064 million (23.3% margin) |
| Operating Income | $219 million (2.5% margin) | $312 million (3.5% margin) |
| Net Earnings | $202 million | $246 million |
| Diluted EPS | $0.95 | $1.13 |
| Operating Cash Flow | $34 million | $156 million |
| Cash & Equivalents | $1,147 million | $1,214 million |
| Total Debt (Long-term + Current) | $1,163 million | $1,149 million |
Material Changes vs. Prior Period
- Restructuring Charges: Operating income declined primarily due to $109 million in restructuring charges, compared to $15 million in the prior year. These charges relate to the "Best Buy Health Optimization and China Sourcing Initiative," including a $73 million asset impairment for a component of the Best Buy Health business.
- Revenue Mix: While total revenue declined 0.9%, the Domestic segment saw growth in Computing and Mobile Phones (+5.8% comparable sales) offset by declines in Appliances (-8.1%) and Entertainment (-13.3%).
- Tax Rate: The effective tax rate dropped to 8.6% from 24.7%, driven by discrete tax benefits associated with the restructuring charges and asset impairments.
- Cash Flow: Operating cash flow decreased significantly to $34 million due to timing of inventory purchases and payments, despite positive earnings.
Guidance, Outlook, and Risks
- Restructuring Outlook: Management does not expect to incur material future restructuring charges related to the current Best Buy Health initiative. The company plans to exit a component of the Best Buy Health business within fiscal 2026.
- Store Count: Best Buy expects to reduce its Domestic store count by approximately 5 to 10 stores in fiscal 2026.
- Tariff Risks: The company faces uncertainty regarding tariffs, noting that approximately 30% to 35% of purchased products rely on vendor imports from China. Management is working with vendors to mitigate impacts.
- Capital Allocation: The company repurchased $100 million of common stock and paid $202 million in dividends. $3.2 billion remains available under the current share repurchase program.
- Liquidity: A new $1.25 billion five-year revolving credit facility was entered into on April 18, 2025, replacing the previous facility. No borrowings were outstanding as of May 3, 2025.
Investor Verification Checklist
- Restructuring Impact: Verify the long-term profitability implications of exiting the Best Buy Health component and the specific nature of the $73 million asset impairment.
- Inventory Management: Monitor the timing of inventory purchases and accounts payable, which significantly impacted operating cash flow this quarter.
- Tariff Exposure: Assess the potential financial impact of future tariff changes on the 30-35% of products sourced via China vendors.
- Segment Performance: Track the divergence between high-growth categories (Computing/Mobile) and declining categories (Appliances/Entertainment) to gauge future revenue stability.
- Debt Covenants: Confirm compliance with the new credit facility's quarterly cash flow leverage ratio covenant.